Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/2/26 19:43 | 4/1/26 | LGND | Health | Drug | Pharmaceutical Preparations | Kozarich John W | FL | D | 3 | S | -280 | 199.54 | 0 | -1 | 43 | D | ||||||||||||||||
4/2/26 18:56 | 4/1/26 | LGND | Health | Drug | Pharmaceutical Preparations | Reardon Andrew | FL | O | CLO,Secr | 2 | S.d | -2,038 | 203.80 | 0 | -10 | 41 | D | |||||||||||||||
3/31/26 17:53 | 3/6/26 | LGND | Health | Drug | Pharmaceutical Preparations | Lamattina John L | FL | D | 1 | S.d | -434 | 200.76 | 0 | -2 | 31 | D | ||||||||||||||||
3/25/26 11:13 | 3/23/26 | LGND | Health | Drug | Pharmaceutical Preparations | Sabba Stephen L | NY | D | 2 | S.d | -618 | 203.60 | 0 | -3 | 34 | D | ||||||||||||||||
3/13/26 19:29 | 3/11/26 | LGND | Health | Drug | Pharmaceutical Preparations | Espinoza Octavio | FL | O | CFO | 2 | S.d | -3,451 | 209.38 | 0 | -16 | 22 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |